Mersana Therapeutics, Inc. (MRSN)
Jan 6, 2026 - MRSN was delisted (reason: acquired by DAWN)
29.08
+0.04 (0.14%)
Inactive Ā· Last trade price on Jan 5, 2026
Mersana Therapeutics Employees
Mersana Therapeutics had 102 employees as of December 31, 2024. The number of employees decreased by 21 or 17.07% compared to the previous year.
Employees
102
Change (1Y)
-21
Growth (1Y)
-17.07%
Revenue / Employee
$325,294
Profits / Employee
-$687,069
Market Cap
145.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 102 | -21 | -17.07% |
| Dec 31, 2023 | 123 | -105 | -46.05% |
| Dec 31, 2022 | 228 | 59 | 34.91% |
| Dec 31, 2021 | 169 | 59 | 53.64% |
| Dec 31, 2020 | 110 | 27 | 32.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
MRSN News
- 11 months ago - Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN - PRNewsWire
- 1 year ago - Day One Biopharmaceuticals to Acquire Mersana Therapeutics - GlobeNewsWire
- 1 year ago - Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025 - GlobeNewsWire
- 1 year ago - Mersana Therapeutics Provides Business Update and AnnouncesĀ Second Quarter 2025 Financial Results - GlobeNewsWire
- 1 year ago - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025 - GlobeNewsWire
- 1 year ago - Mersana Therapeutics Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 1 year ago - Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting - GlobeNewsWire
- 1 year ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire